Great Novel Therapeutics Biotech &amp; Medicals Corporation (GNTbm) Presented Preclinical Data on GNTnm-38, an Novel Epigenetic Immune Activator, at the 2025 ASCO Annual Meeting - Thailand PR News

 - [Banking](https://thailandbusinessnews.net/category/banking/)
- [Companies](https://thailandbusinessnews.net/category/companies/)
- [Economy](https://thailandbusinessnews.net/category/economy/)
- [Press Releases](https://thailandbusinessnews.net/category/press-release/)
    - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/)
- [Tech](https://thailandbusinessnews.net/category/tech/)
- [Tourism](https://thailandbusinessnews.net/category/tourism/)

    - [Press Release](https://thailandbusinessnews.net/category/press-release/)

# Great Novel Therapeutics Biotech &amp; Medicals Corporation (GNTbm) Presented Preclinical Data on GNTnm-38, an Novel Epigenetic Immune Activator, at the 2025 ASCO Annual Meeting

   #####  Up next

  ![Binggrae to Expand Presence in Southeast Asia Through Participation in 'THAIFEX 2025'](https://i0.wp.com/r2.thailandbusinessnews.net/2025/05/A_bird_s_eye_view_of_the_booth_of_Binggrae__THAIFEX_2025.jpg?resize=200%2C110&ssl=1 "Binggrae to Expand Presence in Southeast Asia Through Participation in 'THAIFEX 2025'")

 [](https://thailandbusinessnews.net/press-release/binggrae-to-expand-presence-in-southeast-asia-through-participation-in-thaifex-2025/)

 ###### [Binggrae to Expand Presence in Southeast Asia Through Participation in 'THAIFEX 2025'](https://thailandbusinessnews.net/press-release/binggrae-to-expand-presence-in-southeast-asia-through-participation-in-thaifex-2025/)

  Published on 23 May 2025 #####  Author

#####   [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/)

  ##### Tags

- [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/)

 TAIPEI, May 23, 2025 /PRNewswire/ — GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-38, an novel epigenetic immune activator for cancer immunotherapy. GNTbm-38 was presented as posters at the 2025 American Association of Clinical Oncology (ASCO) Annual Meeting, which is held in Chicago, USA, from May 30 to Jun 04, 2025.

 Abstract: 2574

 Title: Preclinical development of GNTbm-38, a novel class I histone deacetylase inhibitor, while combined with anti-VEGFR TKI or anti-PD-1 Ab: Assessment of immune activation and immune memory in cancer immunotherapy.

 Session Date/Time: 6/2/2025, 1:30 PM-4:30 PM CT

 Poster Board Number: 221

At present, there is no ICI-based drug combination for the treatment of advanced MSS colorectal cancer, which is a cold tumor. Studies have shown that epigenetic regulators such as class I HDAC inhibitors are an emerging and important drug component for combination therapy that can greatly increase the anti-cancer benefits of cancer immunotherapy. Therefore, rational drug combinations, containing class I HDACi, may provide opportunities in cancer immunotherapy.

GNTbm-38 is a new drug candidate independently developed by GNTbm. GNTbm-38 acts as a TME reprogramming regulator in immunotherapy. When combined with TKI, GNTbm-38 significantly improved tumor response rate and survival rate through synergistic effect by normalizing tumor vessels, increasing tumor antigen presentation, increasing activated CD8+ T cell infiltration into tumors, inducing memory T cell persistence, and inhibiting mobilization of immunosuppressive cells into tumors. On the other hand, treatment with GNTbm-38 plus anti-PD-1 antibody in the CT-26 model showed greatly improved tumor response rate and survival rate with a strong synergistic effect. Furthermore, in B-hPD-1/hPD-L1 mice (humanized model) subcutaneously injected with B-hPD-L1 CT-26 cells, treatment of pembrolizumab and GNTbm-38 resulted in a 46.5% inhibition on tumor growth. Therefore, our data provided a strong rationale to explore the combination of GNTbm-38 with anti-VEGF TKI with or without ICI. From these data GNTm-38 has been shown to display powerful induction of immune activation and immune memory in combination therapy with TKI/ICI against colon CT-26 cold tumor. Based on the in vitro, in vivo and preclinical studies, these data show that GNTbm-38 exhibits markedly superior pharmacokinetics, tolerability, and efficacy in animal models. It is expected to complete the US IND application by the end of 2025 and enter the clinical study.

 About GNTbm-38

GNTbm-38 is a new chemical entity with potential as a pivotal drug component of a new generation of cancer immunotherapy independently developed by GNTbm. It is a drug candidate selected by an immuno-competent tumor-bearing animal testing platform, and has undergone many preclinical research studies to confirm that it has very outstanding anti-cancer activity in tumor microenvironment. GNTbm-38 is an oral drug with dual effects of epigenetic regulation of gene expression and immune activation, which is unique when compared to the mechanism of other epigenetic drugs. GNTbm-38 can remodel the tumor microenvironment (TME) through a unique epigenetic regulatory mechanism, including the cell composition and gene expression that affect the TME, so that "cold tumors" can be transformed into "hot tumors", which can attract CTL to infiltrate into the TME, and at the same time, it can also reduce the attraction of immunosuppressive cells (such as : TAM, Treg, and MDSCs) into the TME, so as to achieve the remodeling of the TME, which is more conducive to obtaining the therapeutic benefits of cancer immunotherapy. GNTbm-38 monotherapy can be used in the treatment of hematological tumors, and GNTbm-38 can also be combined with a unique multi-kinase inhibitor or immune checkpoint inhibitor for treatment of a variety of solid tumors, mainly through a unique anti-cancer immune-regulating mechanism to achieve anti-cancer treatment goals.

 About GNTbm

GNTbm (stock code: 7427, Taiwan) is a company that has conducted clinical trials and developed a new drug against advanced breast cancer on the market in Taiwan. The GNTbm R&amp;D team has the ability to independently develop new drugs, and has multiple anti-cancer drug candidates with global development rights, with the goal of meeting the unmet clinical needs of patients with advanced cancers. GNTbm mainly focuses on the development of drugs with innovative mechanisms for the new generation of cancer immunotherapy, conducts clinical validation, and hopes to successfully provide novel immunotherapy with excellent efficacy and safety for varieties of cancer indications, to fulfil the unmet medical needs of patients around the world and improve the quality of life of patients.

[Source link ](https://www.prnasia.com/story/archive/4692768_AE92768_0?rand=89749)

```
This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
```

  #####  You May Also Like

  [](https://thailandbusinessnews.net/press-release/ooredoo-group-signs-framework-agreement-with-polystar-part-of-elisa-industriq-for-mobile-and-fixed-broadband-analytics-boosted-by-ai-and-dataops/) ## Ooredoo Group signs framework agreement with Polystar, part of Elisa Industriq, for mobile and fixed broadband analytics, boosted by AI and DataOps

  Multi-phase deployment brings advanced analytics for mobile and fixed broadband networks, building…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- February 3, 2026

   [](https://thailandbusinessnews.net/press-release/arkieva-recognized-as-great-supply-chain-partner-for-improving-efficiency-and-visibility-for-wells-enterprises/) ## Arkieva recognized as Great Supply Chain Partner for improving efficiency and visibility for Wells Enterprises

  Leading supply chain publication honors end-to-end demand and production planning project at…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- October 14, 2025

   [](https://thailandbusinessnews.net/press-release/hash-asset-managements-lawsuit-vs-ichi-crypto-founders-and-associates-new-forensic-report-shows-collusion-and-insider-trading-in-a-fraud-pump-and-dump-scheme/) ![HASH Asset Management's Lawsuit vs. ICHI Crypto Founders and Associates: New Forensic Report Shows Collusion and Insider Trading in a Fraud, 'Pump-and-Dump' Scheme](https://i0.wp.com/mma.prnasia.com/media2/2861592/HASH_Asset_Management.jpg?resize=260%2C140&ssl=1 "HASH Asset Management's Lawsuit vs. ICHI Crypto Founders and Associates: New Forensic Report Shows Collusion and Insider Trading in a Fraud, 'Pump-and-Dump' Scheme")

- [Press Release](https://thailandbusinessnews.net/category/press-release/)

 ## HASH Asset Management's Lawsuit vs. ICHI Crypto Founders and Associates: New Forensic Report Shows Collusion and Insider Trading in a Fraud, 'Pump-and-Dump' Scheme

  The HASH vs ICHI lawsuit presents claims for crypto fraud and theft for…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- January 15, 2026

 ##### Most Read

- [![Manulife appoints Sarah Chapman as Global Chief Marketing & Customer Experience Officer, joining Executive Leadership Team](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/manulife-appoints-sarah-chapman-as-global-chief-marketing-customer-experience-officer-joining-executive-leadership-team/ "Manulife appoints Sarah Chapman as Global Chief Marketing & Customer Experience Officer, joining Executive Leadership Team") [Manulife appoints Sarah Chapman as Global Chief Marketing &amp; Customer Experience Officer, joining Executive Leadership Team](https://thailandbusinessnews.net/press-release/manulife-appoints-sarah-chapman-as-global-chief-marketing-customer-experience-officer-joining-executive-leadership-team/ "Manulife appoints Sarah Chapman as Global Chief Marketing & Customer Experience Officer, joining Executive Leadership Team")
- [![ReThink HK 2026 Opens at HKCEC, Bringing Business, Government and NGOs Together to Accelerate Climate Action](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/rethink-hk-2026-opens-at-hkcec-bringing-business-government-and-ngos-together-to-accelerate-climate-action/ "ReThink HK 2026 Opens at HKCEC, Bringing Business, Government and NGOs Together to Accelerate Climate Action") [ReThink HK 2026 Opens at HKCEC, Bringing Business, Government and NGOs Together to Accelerate Climate Action](https://thailandbusinessnews.net/press-release/rethink-hk-2026-opens-at-hkcec-bringing-business-government-and-ngos-together-to-accelerate-climate-action/ "ReThink HK 2026 Opens at HKCEC, Bringing Business, Government and NGOs Together to Accelerate Climate Action")
- [![Fashion Summit (HK) 2026 "Code the Fashion Forward" at the Hong Kong Palace Museum: Global Fashion Leaders, Innovators, and Local Design Talents Gather, Sharing Insights to Co-create a Green and Smart New Chapter in Fashion](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/fashion-summit-hk-2026-code-the-fashion-forward-at-the-hong-kong-palace-museum-global-fashion-leaders-innovators-and-local-design-talents-gather-sharing-insights-to-co-create-a-green/ "Fashion Summit (HK) 2026 "Code the Fashion Forward" at the Hong Kong Palace Museum: Global Fashion Leaders, Innovators, and Local Design Talents Gather, Sharing Insights to Co-create a Green and Smart New Chapter in Fashion") [Fashion Summit (HK) 2026 "Code the Fashion Forward" at the Hong Kong Palace Museum: Global Fashion Leaders, Innovators, and Local Design Talents Gather, Sharing Insights to Co-create a Green and Smart New Chapter in Fashion](https://thailandbusinessnews.net/press-release/fashion-summit-hk-2026-code-the-fashion-forward-at-the-hong-kong-palace-museum-global-fashion-leaders-innovators-and-local-design-talents-gather-sharing-insights-to-co-create-a-green/ "Fashion Summit (HK) 2026 "Code the Fashion Forward" at the Hong Kong Palace Museum: Global Fashion Leaders, Innovators, and Local Design Talents Gather, Sharing Insights to Co-create a Green and Smart New Chapter in Fashion")
- [![Midea Unveils VitaBreeze: An AC Beyond Cooling and Heating](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/midea-unveils-vitabreeze-an-ac-beyond-cooling-and-heating/ "Midea Unveils VitaBreeze: An AC Beyond Cooling and Heating") [Midea Unveils VitaBreeze: An AC Beyond Cooling and Heating](https://thailandbusinessnews.net/press-release/midea-unveils-vitabreeze-an-ac-beyond-cooling-and-heating/ "Midea Unveils VitaBreeze: An AC Beyond Cooling and Heating")
- [![Alpha Ladder WealthX Among Asia's First to Bring xStocks US Tokenised Equities to Institutional and Accredited Investors](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/alpha-ladder-wealthx-among-asias-first-to-bring-xstocks-us-tokenised-equities-to-institutional-and-accredited-investors/ "Alpha Ladder WealthX Among Asia's First to Bring xStocks US Tokenised Equities to Institutional and Accredited Investors") [Alpha Ladder WealthX Among Asia's First to Bring xStocks US Tokenised Equities to Institutional and Accredited Investors](https://thailandbusinessnews.net/press-release/alpha-ladder-wealthx-among-asias-first-to-bring-xstocks-us-tokenised-equities-to-institutional-and-accredited-investors/ "Alpha Ladder WealthX Among Asia's First to Bring xStocks US Tokenised Equities to Institutional and Accredited Investors")
- [![SJourney Enters a New Chapter with Arsenale's 33% Strategic Investment](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/sjourney-enters-a-new-chapter-with-arsenales-33-strategic-investment/ "SJourney Enters a New Chapter with Arsenale's 33% Strategic Investment") [SJourney Enters a New Chapter with Arsenale's 33% Strategic Investment](https://thailandbusinessnews.net/press-release/sjourney-enters-a-new-chapter-with-arsenales-33-strategic-investment/ "SJourney Enters a New Chapter with Arsenale's 33% Strategic Investment")

##### Subscribe via Email

 Enter your email address to subscribe and receive notifications of new posts by email.

  Email Address

       Subscribe

  [](https://thailandbusinessnews.net/press-release/amid-a-changing-global-landscape-countries-seek-investment-opportunities-at-cifit/) ![Amid a Changing Global Landscape, Countries Seek Investment Opportunities at CIFIT](https://i0.wp.com/mmx.prnasia.com/media/MS1986889/20260912013516EDT_image_1.jpg?resize=260%2C140&ssl=1 "Amid a Changing Global Landscape, Countries Seek Investment Opportunities at CIFIT")

 ## Amid a Changing Global Landscape, Countries Seek Investment Opportunities at CIFIT

  Click to learn more: https://youtube.com/shorts/gZ3xQzfZhoo?si=hCiDYS9P0_P32ve7 …

   [](https://thailandbusinessnews.net/press-release/qivika-to-launch-smart-scope-on-kickstarter-bringing-a-professional-long-range-experience-to-day-and-night-exploration/) ![QIVIKA to Launch Smart Scope on Kickstarter, Bringing a Professional Long-Range Experience to Day-and-Night Exploration](https://i0.wp.com/mmx.prnasia.com/media/MS1986483/20260911084649EDT_image_1.jpg?resize=260%2C140&ssl=1 "QIVIKA to Launch Smart Scope on Kickstarter, Bringing a Professional Long-Range Experience to Day-and-Night Exploration")

 ## QIVIKA to Launch Smart Scope on Kickstarter, Bringing a Professional Long-Range Experience to Day-and-Night Exploration

  BERLIN and NEW YORK, Sept. 12, 2026 /PRNewswire/ — QIVIKA, a consumer…

   [](https://thailandbusinessnews.net/press-release/the-generation-essential-groups-receipt-of-nyse-letter-regarding-class-a-ordinary-shares-trading-price/) ## The Generation Essential Group's Receipt of NYSE Letter Regarding Class A Ordinary Shares Trading Price

  NEW YORK and LONDON, Sept. 12, 2026 /PRNewswire/ — The Generation Essentials…

   [](https://thailandbusinessnews.net/press-release/quantinuum-to-participate-in-the-piper-sandler-5th-annual-growth-frontiers-conference/) ## Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference

  BROOMFIELD, Colo., Sept. 12, 2026 /PRNewswire/ — Quantinuum Inc. (Nasdaq: QNT)…
<!-- Performance optimized by Docket Cache: https://wordpress.org/plugins/docket-cache -->
